Whiz Partners
Whiz Partners is a private equity and venture capital firm that invests in the healthcare industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Whiz Partners Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Whiz Partners is a private equity and venture capital firm that invests in the healthcare industry.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2018 | WHILL | Series C | 0 |
| 9/2015 | NanoCarrier Co | Post-IPO Debt | 25.7M |
| 12/2016 | Immuno-Biological Laboratories | Post-IPO Debt | 0 |
| 11/2016 | ALBERT | Post-IPO Debt | 0 |
| 6/2016 | Medrx | Post-IPO Debt | 0 |
| 9/2015 | Medinet Co | Post-IPO Equity | 4.3M |
| 4/2017 | Tocagen | Post-IPO Equity | 0 |
| 1/2012 | NanoCarrier Co | Post-IPO Debt | 22.1M |
| 10/2017 | Inspec | Post-IPO Equity | 48k |
| 4/2014 | Nanodex | Venture Round | 406.1k |
| 12/2012 | SymBio Pharmaceuticals | Post-IPO Equity | 11.7M |
| 11/2016 | FRONTEO | Post-IPO Debt | 0 |
| 5/2013 | Advanced Media | Post-IPO Equity | 15.3M |
| 12/2019 | Caresyntax | Equity | 45.6M |
| 3/2014 | CellSeed | Post-IPO Equity | 5M |
| 5/2015 | DIGITAL HEARTS HOLDINGS | Post-IPO Debt | 8.5M |
| 10/2017 | CLARRO Inc. | Post-IPO Debt | 0 |
| 11/2015 | CRI Middleware Co., Ltd. | Post-IPO Debt | 5.3M |
| 2/2013 | Gene Techno Science | Post-IPO Equity | 13.2M |
| 4/2016 | SymBio Pharmaceuticals | Post-IPO Debt | 0 |
| 5/2010 | SymBio Pharmaceuticals | Venture Round | 5.9M |
| 8/2014 | Shoubunsha Publications | Post-IPO Equity | 9.8M |
| 12/2019 | Caresyntax | Series B | 0 |
| 9/2018 | WHILL | Series C | 0 |
| 10/2017 | Inspec | Post-IPO Equity | 0 |
| 10/2017 | CLARRO Inc. | Post-IPO Debt | 0 |
| 4/2017 | Tocagen | Post-IPO Equity | 0 |
| 12/2016 | Immuno-Biological Laboratories | Post-IPO Debt | 0 |
| 11/2016 | ALBERT | Post-IPO Debt | 0 |
| 11/2016 | FRONTEO | Post-IPO Debt | 0 |
| 6/2016 | Medrx | Post-IPO Debt | 0 |
| 4/2016 | SymBio Pharmaceuticals | Post-IPO Debt | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
